A cure for migraines? New drug gets EU approval
NHS to consider offering preventative injections which cut migraine rate by half
The first licensed drug proven to be effective in preventing migraines may soon be available in the UK, after EU regulators gave it the green light.
The European Medicines Agency has approved Erenumab, specifically designed to prevent the onset of migraines, opening the door for the treatment to be made available on the NHS.
“Even were it turned down by public health officials, the manufacturer Novartis has said that patients would be able to access the medicine privately from September,” Sky News reports. The drug, which can be injected by the patient at home, works by blocking a receptor in the brain which is believed to be involved in triggering migraines - “although scientists are not completely sure what causes the agonising headaches just yet”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In clinical trials, “one in four patients with chronic migraines - those experiencing symptoms 15 days or more a month - were migraine-free for more than 15 months,” The Scientist reports.
On average, Erenumab cut the number of days that volunteers experienced a migraine in a month by half.
Wendy Thomas, the chief executive of the Migraine Trust, said the decision to approve the drug for sale in the EU was “wonderful”.
“This new treatment has the potential to help many people with chronic and episodic migraine,” she said, a condition which “can literally ruin lives”.
A world survey of health conditions across 195 countries found that, “in every year from 1990 to 2016, migraine attacks remained the second-largest global contributor to years lived with disability”, writes journalist and migraine sufferer Lauren Sharkey for the BBC.
As well as causing misery for millions, migraines also come with an economic cost. In the UK alone, the extreme headaches are responsible for around 25 million sick days taken every year.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Alcohol-free drinks for Sober October
The Week Recommends These are the best booze-free tipples from refreshing pale ales to bittersweet aperitifs
By Irenie Forshaw, The Week UK Published
-
Israel's wars: is an end in sight – or is this just the beginning?
Today's Big Question Lack of wider strategic vision points to 'sustained low-intensity war' on multiple fronts
By Elliott Goat, The Week UK Published
-
How can you save on homeowners insurance?
The Explainer With the rise in extreme weather, house protection is a non-negotiable
By Becca Stanek, The Week US Published
-
A 'transformative' gene therapy for haemophilia B
The Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost
By Julia O'Driscoll, The Week UK Published
-
Infected blood scandal: will justice be served?
Today's Big Question Government apologises for 'decades-long moral failure' and promises £10bn compensation but true accountability may take far longer
By Harriet Marsden, The Week UK Published
-
Immunotherapy and hay fever
The Explainer Research shows that the treatment could provide significant relief from symptoms for many hay fever sufferers
By Richard Windsor, The Week UK Published
-
The pros and cons of universal health care
Pros and Cons A medical system that serves everyone comes with its own costs, and they're not only financial
By Rebecca Messina, The Week UK Published
-
Martha's Rule: patients given right to urgent second opinion
The Explainer Hospitals in England will launch new scheme that will allow access to a rapid treatment review
By Richard Windsor, The Week UK Published
-
The contaminated blood scandal
The Explainer Widely regarded as the worst treatment disaster in the history of the NHS, the public inquiry is due to publish its report in May
By The Week UK Published
-
Can Britain's dental crisis be fixed?
The Explainer New proposals include more money for dentists working in under-served areas
By Richard Windsor, The Week UK Published
-
Babylon Health: the failed AI wonder app that 'dazzled' politicians
The Explainer Demise of UK tech start-up is a cautionary tale for politicians seeking quick fixes to complicated problems
By The Week UK Last updated